Correlation Between Novo Nordisk and Superior Plus

Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and Superior Plus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and Superior Plus into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Novo Nordisk AS and Superior Plus Corp, you can compare the effects of market volatilities on Novo Nordisk and Superior Plus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of Superior Plus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and Superior Plus.

Diversification Opportunities for Novo Nordisk and Superior Plus

-0.09

Correlation Coefficient

Novo Nordisk  Superior Plus

Good diversification

The 3 months correlation between Novo and Superior is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and Superior Plus Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Superior Plus Corp and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with Superior Plus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Superior Plus Corp has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and Superior Plus go up and down completely randomly.

Pair Corralation between Novo Nordisk and Superior Plus

Assuming the 90 days trading horizon Novo Nordisk AS is expected to under-perform the Superior Plus. In addition to that, Novo Nordisk is 1.41 times more volatile than Superior Plus Corp. It trades about -0.14 of its total potential returns per unit of risk. Superior Plus Corp is currently generating about 0.03 per unit of volatility. If you would invest  406.00  in Superior Plus Corp on December 29, 2024 and sell it today you would earn a total of  8.00  from holding Superior Plus Corp or generate 1.97% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Novo Nordisk AS  vs.  Superior Plus Corp

Novo Nordisk AS

Risk-Adjusted Performance

Very Weak

Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Superior Plus Corp

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Superior Plus Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Superior Plus is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Novo Nordisk and Superior Plus

The main advantage of trading using opposite Novo Nordisk and Superior Plus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, Superior Plus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Superior Plus will offset losses from the drop in Superior Plus' long position.

The idea behind Novo Nordisk AS and Superior Plus Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.